However, I think for markets with India perspective we are very-very light right now, we still like to see over the next couple of days of what transpires on the political front and therefore the initiatives that will be taken over the next few days and specifically in the budget in terms of allocations are going to be extremely critical.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale